Shuanghuanglian Oral Liquid
- Generic Name
- Shuanghuanglian Oral Liquid
Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection
Phase 1
Completed
- Conditions
- Acute Upper Respiratory Tract InfectionRandomised Controlled TrialTraditional Chinese Medicine
- Interventions
- Drug: Qing Re He Ji
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 268
- Registration Number
- NCT06520618
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath